Identification of the beneficial population for Shenlingcao oral liquid in non-small cell lung cancer using the Rboost method

Authors
Category Primary study
JournalChin. J. Evid.-Based Med.
Year 2026
This article has no abstract
Epistemonikos ID: 44fbb213017c06dd9794a2c46b752c6b1a388f0b
First added on: Sep 05, 2026